These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27091198)

  • 1. Filling the Knowledge Gap in Diabetes Management During Ramadan: the Evolving Role of Trial Evidence.
    Al Sifri S; Rizvi K
    Diabetes Ther; 2016 Jun; 7(2):221-40. PubMed ID: 27091198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of vildagliptin relative to sulfonylurea as dual therapy with metformin (or as monotherapy) in Muslim patients with type 2 diabetes fasting during Ramadan in the Middle East: the VIRTUE study.
    Hassoun AA; Al-Arouj M; Ibrahim M
    Curr Med Res Opin; 2017 Jan; 33(1):161-167. PubMed ID: 27684469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review on efficacy and safety of the current hypoglycemic agents in patients with diabetes during Ramadan fasting.
    Rashid F; Abdelgadir E
    Diabetes Metab Syndr; 2019; 13(2):1413-1429. PubMed ID: 31336501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approach.
    Mbanya JC; Al-Sifri S; Abdel-Rahim A; Satman I
    Diabetes Res Clin Pract; 2015 Aug; 109(2):226-32. PubMed ID: 26003888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Vildagliptin Versus Sulfonylurea in Muslim Patients with Type 2 Diabetes Fasting During Ramadan in Egypt: Results from VIRTUE Study.
    Khattab M; Mahmoud K; Shaltout I
    Diabetes Ther; 2016 Sep; 7(3):551-60. PubMed ID: 27550549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study.
    Aravind SR; Ismail SB; Balamurugan R; Gupta JB; Wadhwa T; Loh SM; Suryawanshi S; Davies MJ; Girman CJ; Katzeff HL; Radican L; Engel SS; Wolthers T
    Curr Med Res Opin; 2012 Aug; 28(8):1289-96. PubMed ID: 22738801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fructosamine as an Index of Short-Term Glycemic Control in Pregnant Women with Diabetes: Before, During and After Ramadan.
    Ekhzaimy A; Alkatari S; AlMaatouq M; Alotaibi D; Aljasser S; Aseeri A; Jammah A; Mujammami M; Fouda M; Alfadda AA; Sulaimani R
    Int J Womens Health; 2022; 14():435-444. PubMed ID: 35386939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients.
    Aziz KM
    Diabetes Metab Syndr Obes; 2015; 8():207-11. PubMed ID: 25931826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study.
    Hassanein M; Hanif W; Malik W; Kamal A; Geransar P; Lister N; Andrews C; Barnett A
    Curr Med Res Opin; 2011 Jul; 27(7):1367-74. PubMed ID: 21568833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the Effect of Ramadan Fasting on Muslim Patients with Diabetes in relation to Use of Medication and Lifestyle Patterns: A Prospective Study.
    Siaw MY; Chew DE; Dalan R; Abdul Shakoor SA; Othman N; Choo CH; Shamsuri NH; Abdul Karim SN; Chan SY; Lee JY
    Int J Endocrinol; 2014; 2014():308546. PubMed ID: 25435876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment adherence with vildagliptin compared to sulphonylurea as add-on to metformin in Muslim patients with type 2 diabetes mellitus fasting during Ramadan.
    Hanif W; Malik W; Hassanein M; Kamal A; Geransar P; Andrews C; Azam M; Barnett AH
    Curr Med Res Opin; 2013 Jul; 29(7):807-11. PubMed ID: 23659561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The characteristics and pattern of care for the type 2 diabetes mellitus population in the MENA region during Ramadan: An international prospective study (DAR-MENA T2DM).
    Hassanein M; Al Awadi FF; El Hadidy KES; Ali SS; Echtay A; Djaballah K; Dessapt-Baradez C; Khazaal FAK; Abu-Hijleh MO; Al Shaikh A; Gharbi MEH; Shehadeh N; Bennakhi A; Al Arouj M
    Diabetes Res Clin Pract; 2019 May; 151():275-284. PubMed ID: 30825560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitudinal determinants of fasting in type 2 diabetes mellitus patients during Ramadan.
    Fatim J; Karoli R; Chandra A; Naqvi N
    J Assoc Physicians India; 2011 Oct; 59():630-4. PubMed ID: 22479742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of diet, sulfonylurea, and Repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan.
    Sari R; Balci MK; Akbas SH; Avci B
    Endocr Res; 2004 May; 30(2):169-77. PubMed ID: 15473127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for managing diabetes in Ramadan.
    Ali S; Davies MJ; Brady EM; Gray LJ; Khunti K; Beshyah SA; Hanif W
    Diabet Med; 2016 Oct; 33(10):1315-29. PubMed ID: 26802436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes during Ramadan - PRE-approach model: presentation, risk stratification, education.
    Hassan A; Meo SA; Usmani AM; Shaikh TJ
    Eur Rev Med Pharmacol Sci; 2014; 18(12):1798-805. PubMed ID: 24992624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care.
    Alawadi F; Rashid F; Bashier A; Abdelgadir E; Al Saeed M; Abuelkheir S; Khalifa A; Al Sayyah F; Bachet F; Elsayed M; Abdallah K; Hassanein M
    Diabetes Res Clin Pract; 2019 May; 151():305-312. PubMed ID: 30880094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge of diabetes mellitus and safe practices during Ramadan fasting among Muslim patients with diabetes mellitus in Singapore.
    Zainudin SB; Ang DY; Soh AW
    Singapore Med J; 2017 May; 58(5):246-252. PubMed ID: 27121922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
    Bakiner O; Ertorer ME; Bozkirli E; Tutuncu NB; Demirag NG
    Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.